BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 12901591)

  • 1. Therapeutic AIDS vaccine looks promising.
    Expert Rev Vaccines; 2003 Feb; 2(1):5. PubMed ID: 12901591
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.
    Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM
    Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
    Kato M; Igarashi H; Takeda A; Horie S; Higashihara E; Matano T
    Jpn J Infect Dis; 2004 Oct; 57(5):220-3. PubMed ID: 15507782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity in natural SIV infections.
    Silvestri G
    J Intern Med; 2009 Jan; 265(1):97-109. PubMed ID: 19093963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
    Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ
    Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the relative therapeutic effects of vaccines on virus load and immune responses in small groups at several time points: efficacy of mucosal and subcutaneous polypeptide vaccines in rhesus macaques exposed to SHIV.
    Kuznetsov VA; Stepanov VS; Berzofsky JA; Belyakov IM
    J Clin Virol; 2004 Dec; 31 Suppl 1():S69-82. PubMed ID: 15567097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
    Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
    J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
    Uberla K; Rosenwirth B; Ten Haaft P; Heeney J; Sutter G; Erfle V
    J Med Primatol; 2007 Feb; 36(1):2-9. PubMed ID: 17359459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The thymus gland of rhesus macaque in SIV vaccination/infection].
    Baroni CD; Pescarmona E; Sebastiani S; Uguccioni M
    Pathologica; 2003 Oct; 95(5):230. PubMed ID: 14988981
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity in experimental SIV infection and vaccination.
    Ahmed RK; Biberfeld G; Thorstensson R
    Mol Immunol; 2005 Feb; 42(2):251-8. PubMed ID: 15488612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
    Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
    J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Deltanef.
    Georgsson G; Stahl-Hennig C; Tenner-Racz K; Uberla K; Stoiber H; Uguccioni M; Dierich M; Ignatius R; Steinman RM; Racz P
    Neuropathol Appl Neurobiol; 2007 Dec; 33(6):644-57. PubMed ID: 17573813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.